Pilot Study of Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage
Subarachnoid Hemorrhage · Seizures
Enrolment: 0 · Results not recorded
Drug · MODULATOR of synaptic vesicle glycoprotein 2A (SV2A); BLOCKER of voltage-gated N-type calcium channel alpha-1B subunit.
1 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Subarachnoid Hemorrhage · Seizures
Enrolment: 0 · Results not recorded
Focal Epilepsy
Enrolment: 75 · Results not recorded
Tonic-clonic Seizure
Enrolment: 158 · Results not recorded
Epilepsy
Enrolment: 3 · Results not recorded
Multiple Sclerosis
Enrolment: 30 · Results not recorded
Neonatal Seizures · HIE
Enrolment: 66 · Results not recorded
Epilepsy · Drug Resistant
Enrolment: 112 · Results not recorded
Epilepsy, Partial
Enrolment: 11 · Results not recorded
Epilepsy
Enrolment: 228 · Results not recorded
Epilepsy
Enrolment: 190 · Results not recorded
Epilepsy, Partial
Enrolment: 223 · Results not recorded
Alzheimer Disease
Enrolment: 65 · Results not recorded
Bipolar Disorder
Enrolment: 30 · Results not recorded
Sickle Cell Disease
Enrolment: 43 · Results not recorded
Alzheimer Disease · Mild Cognitive Impairment
Enrolment: 58 · Results not recorded
Epilepsy
Enrolment: 19 · Results not recorded
Healthy
Enrolment: 30 · Results not recorded
Status Epilepticus
Enrolment: 152 · Results not recorded
Refractory Epilepsy
Enrolment: 0 · Results not recorded
4 studies reported at therapy level; 5 evidence entries itemised.
Model: Two models: in vitro traumatised neocortical slices (400 to 450 um, surgical cut separating superficial from deeper layers) and in vivo non-penetrating focal controlled cortical impact to neocortex (5.0 mm diameter, 2.0 mm depth)
Levetiracetam applied within 60 min of injury reduced by more than 50% the proportion of slices showing stimulus-evoked epileptiform activity and raised the stimulus threshold 2 to 4 fold, and in vivo treatment reduced the proportion of animals with spontaneous and evoked epileptiform bursts, sugge…
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.
Model: Severe penetrating ballistic-like brain injury with post-traumatic nonconvulsive seizures monitored by continuous electroencephalography for 72 hours
Levetiracetam 25 to 100 mg/kg and gabapentin 6.25 to 25 mg/kg each reduced seizure frequency and duration, but the combination gave no additional benefit and isobolographic analysis did not reach additivity.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.
Model: T7-8 dorsal laminectomy with temporary vascular aneurysm clip compression of the spinal cord for 1 minute
Both levetiracetam and methylprednisolone improved histopathological architecture during the acute phase but this was not sustained in the subacute period, and neither agent altered biochemical measures at either stage.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.
Model: Acute systemic hypoxia (90 min at 6% oxygen) in neonatal mice, a model of perinatal asphyxia
Hypothermia produced acute and long-term neuroprotection by reducing apoptosis and preserving myelinating oligodendrocytes and neurons. Low-dose levetiracetam caused no adverse effects but added no neuroprotection, whereas high-dose levetiracetam alone or with hypothermia increased neuronal apoptos…
Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.
Extraction: mesh. Machine-extracted fields require source verification.